Navigation Links
Sigma-Aldrich Elects Michael Marberry As Director
Date:9/19/2012

ST. LOUIS, Sept. 19, 2012 /PRNewswire/ -- The Board of Directors of Sigma-Aldrich Corporation (NASDAQ: SIAL) has elected Michael Marberry as a Director of the Company. Mr. Marberry (age 54) is President and CEO of J.M. Huber Corporation, a diversified, multinational supplier of engineered materials, natural resources and technology-based services to customers spanning many industries from paper and energy to plastics and construction.

In announcing Mr. Marberry's election to the Board, Rakesh Sachdev, President and CEO of Sigma-Aldrich, said, "We are extremely pleased to have Michael Marberry join our Board.  His broad background and international experience in leading a successful global company and in expanding into applied chemical and industrial markets will help Sigma-Aldrich in strategic efforts to enhance its leadership position in Life Science and High Technology."

About Sigma-Aldrich:  Sigma-Aldrich is a leading Life Science and High Technology company.  Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing.  The Company has customers in life science companies, university and government institutions, hospitals and in industry.  Over one million scientists and technologists use its products.  Sigma-Aldrich operates in 38 countries and has 9,100 employees providing excellent service worldwide.  The Company is committed to accelerating customer success through innovation and leadership in Life Science, High Technology and Service.  For more information about Sigma-Aldrich, please visit its award winning web site at www.sigma-aldrich.com.


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
2. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
3. Sigma-Aldrich Corporation Announces New Credit Facility
4. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
5. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
6. Netsmart Selects Overland Park, Kansas, for New Office
7. Pharmaceutical Consortium Selects BioFortis Software to Manage Collaborative Clinical Data and Biobanking Activities
8. Avaxia Biologics Elects Christopher Kiritsy to its Board of Directors
9. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
10. Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop Marketing Solution for Apple iPad
11. Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... -- VWR Corporation (NASDAQ: VWR), the leading global independent provider of ... reported its financial results for the fourth quarter and full ... 4Q16 record quarterly net sales of $1.13 billion, ... 4Q16 EMEA-APAC segment net sales ... Americas net sales increased 2.5%, or down 0.9% on an ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... , its innovative, highly flexible and award winning ... customers. iMedNet is a proven Software-as-a-Service ... Electronic Data Capture (EDC), but also delivers an entire ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):